PHAT Phathom Pharmaceuticals, Inc. - Common Stock
$9,67
Precio · Ago 19, 2026
Fundamentales a fecha de Jul 30, 2026
Rango 52S
$8–$18
14% of range
Calificación del Analista
BUY
17 analysts
Precio Objetivo
$22
+122% upside
P/E (TTM)
-3.5
ROE
52.4%
Margen de Beneficio Neto
-126.4%
PHAT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$9.67
Capitalización Bursátil
$768M
P/E (TTM)
-3.5
BPA (TTM)
$-3.03
Ingresos (TTM)
$175M
Rendimiento div.
—
ROE
52.4%
Deuda/Capital
-0.5
Rango 52S
$8 – $18
PHAT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$175M
2022-12-31
→
2025-12-31
BPA
$-3.03
2021-12-31
→
2025-12-31
Flujo de caja libre
$-167M
2019-12-31
→
2025-12-31
Márgenes
-126.4%
2023-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
PHAT
Mediana de Pares
P/E (TTM)
-3.5
11.7
P/S (TTM) (P/V (TTM))
4.4
5.4
P/B (P/C)
-1.8
3.7
EV / EBITDA
-5.3
—
Price / FCF (Precio / FCF)
-4.6
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
PHAT
Mediana de Pares
Gross Margin (Margen Bruto)
87.1%
83.9%
Operating Margin (Margen Operativo)
-91.4%
—
Net Profit Margin (Margen de Beneficio Neto)
-126.4%
-45.6%
ROA
-69.4%
-25.4%
ROE
52.4%
-27.1%
ROIC
69.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
PHAT
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
-0.5
—
Current Ratio (Ratio corriente)
1.7
4.6
Quick Ratio (Ratio Rápido)
1.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
PHAT
Mediana de Pares
Revenue YoY (Ingresos interanuales)
216.9%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
PHAT
Mediana de Pares
PHAT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
17 analistas
- Compra fuerte 6 35,3%
- Compra 9 52,9%
- Mantener 2 11,8%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
10 analistas · 2026-08-18
Mediana
$21.50
← Por Debajo de Todos los Objetivos
$9.67
Mín
$13.00
Máx
$29.00
Objetivo mediano
$21.50
+122,3%
Objetivo medio
$21.50
+122,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.02%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.21 | $-0.26 | 0.05% |
| 31 de marzo de 2026 | $-0.37 | $-0.33 | -0.04% |
| 31 de diciembre de 2025 | $-0.29 | $-0.39 | 0.10% |
| 30 de septiembre de 2025 | $-0.41 | $-0.56 | 0.15% |
| 30 de junio de 2025 | $-1.05 | $-1.06 | 0.01% |
| 31 de marzo de 2025 | $-1.31 | $-1.17 | -0.14% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| SGP | — | — | — | — | 50.0% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $175M | $55M | $682.0K | $0 | |
| Cost of Revenue | $23M | $8M | $167.0K | $0 | |
| Gross Profit | $153M | $47M | $515.0K | $0 | |
| R&D Expense | $33M | $34M | $50M | $71M | |
| SG&A Expense | $280M | $291M | $118M | $101M | |
| Operating Expenses | $312M | $325M | $168M | $172M | |
| Operating Income | $-160M | $-277M | $-167M | $-172M | |
| Interest Expense | · | · | $42M | $27M | |
| Interest Income | $7M | $15M | $8M | $2M | |
| Other Non-op | $-190.0K | $-8.0K | $-188.0K | $-110.0K | |
| Pretax Income | $-221M | $-334M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-221M | $-334M | $-202M | $-198M | |
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| EPS (Diluted) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| Shares (Basic) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| Shares (Diluted) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| EBITDA | $-159M | $-277M | $-167M | $-172M |
Balance general 24
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $130M | $297M | $381M | $155M | |
| Receivables | $78M | $39M | $2M | $0 | |
| Inventory | $6M | $3M | $1M | $0 | |
| Prepaid Expense | $15M | $21M | $13M | $5M | |
| Current Assets | $229M | $360M | $397M | $161M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $3M | $2M | $2M | $299.0K | |
| Total Assets | $259M | $378M | $414M | $165M | |
| Accounts Payable | $5M | $11M | $13M | $10M | |
| Accrued Liabilities | $90M | $53M | $17M | $15M | |
| Current Liabilities | $132M | $86M | $39M | $26M | |
| Capital Leases | $2M | · | $462.0K | $1M | |
| Other Non-current Liabilities | $4M | $12M | $10M | $8M | |
| Total Liabilities | $697M | $632M | $487M | $240M | |
| Long-term Debt | $209M | $201M | $138M | $95M | |
| Total Debt | $209M | $201M | $138M | $95M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-1.48B | $-1.26B | $-929M | $-727M | |
| Treasury Stock | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-438M | $-254M | $-73M | $-75M | |
| Liabilities + Equity | $259M | $378M | $414M | $165M | |
| Shares Outstanding | 71,419,025 | 68,518,238 | 57,970,044 | 41,468,871 |
Flujo de Efectivo 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $633.0K | $795.0K | $575.0K | $620.0K | |
| Stock-based Comp | $29M | $24M | $45M | $24M | |
| Other Non-cash | $25M | $43M | $18M | $26M | |
| Operating Cash Flow | $-167M | $-267M | $-138M | $-147M | |
| CapEx | $229.0K | $135.0K | $2M | $1M | |
| Investing Cash Flow | $-229.0K | $-135.0K | $-2M | $-1M | |
| Debt Issued | $0 | $59M | $39M | $0 | |
| Net Debt Issued | $0 | $59M | $39M | · | |
| Stock Issued | · | · | $14M | · | |
| Financing Cash Flow | $-288.0K | $183M | $368M | $120M | |
| Net Change in Cash | $-167M | $-84M | $228M | $-28M | |
| Free Cash Flow | $-167M | $-267M | $-139M | $-148M |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 87.1% | 85.6% | 75.5% | · | |
| Operating Margin | -91.4% | -502.2% | -24532.5% | · | |
| Net Margin | -126.4% | -605.1% | -29558.9% | · | |
| Pretax Margin | -126.4% | · | · | · | |
| EBITDA Margin | -91.0% | -500.8% | -24448.2% | · | |
| ROA | -69.4% | -84.4% | -69.7% | -111.6% | |
| ROE | 52.4% | 151.7% | 445.4% | 390.6% | |
| ROIC | 69.8% | · | · | · |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 4.2 | 10.2 | 6.1 | |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | |
| Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| LT Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| Interest Coverage | · | · | -4.0 | -6.3 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 3.6 | 0.3 | · | |
| Receivables Turnover | 3.0 | 2.7 | 0.8 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 216.9% | 8001.5% | · | · |
Valoración (TTM) 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $175M | $55M | $682.0K | $0 | |
| Net Income TTM | $-221M | $-334M | $-202M | $-198M | |
| Market Cap | $1.18B | $471M | $529M | $465M | |
| Enterprise Value | $1.26B | $375M | $286M | $405M | |
| P/E | -5.5 | -1.5 | -2.3 | -2.2 | |
| P/S | 6.8 | 8.5 | 776.1 | · | |
| P/B | -2.7 | -1.9 | -7.3 | -6.2 | |
| P / Cash Flow | -7.1 | -1.8 | -3.8 | -3.2 | |
| P / FCF | -7.1 | -1.8 | -3.8 | -3.2 | |
| EV / EBITDA | -7.9 | -1.4 | -1.7 | -2.4 | |
| EV / FCF | -7.6 | -1.4 | -2.1 | -2.7 | |
| EV / Revenue | 7.2 | 6.8 | 418.9 | · | |
| Earnings Yield | -18.3% | -65.1% | -43.0% | -45.0% |
Estado de resultados 16
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $58M | $58M | $50M | $40M | $29M | $30M | $16M | $7M | $2M | $682.0K | $0 | $0 | $0 | |
| Cost of Revenue | $15M | $12M | $8M | $6M | $5M | $4M | $4M | $2M | $1M | $426.0K | $167.0K | $0 | $0 | $0 | |
| Gross Profit | $59M | $46M | $50M | $43M | $34M | $25M | $26M | $14M | $6M | $1M | $515.0K | $0 | $0 | $0 | |
| R&D Expense | $8M | $8M | $7M | $7M | $9M | $9M | $9M | $9M | $7M | $9M | $13M | $12M | $13M | $11M | |
| SG&A Expense | $55M | $54M | $48M | $52M | $85M | $94M | $77M | $76M | $76M | $62M | $57M | $23M | $19M | $19M | |
| Operating Expenses | $63M | $62M | $56M | $59M | $94M | $104M | $85M | $85M | $83M | $71M | $70M | $36M | $32M | $30M | |
| Operating Income | $-4M | $-15M | $-6M | $-15M | $-60M | $-79M | $-59M | $-71M | $-77M | $-70M | $-70M | $-36M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | $18M | $17M | · | $10M | $10M | $9M | |
| Interest Income | $2M | $2M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $348.0K | $1M | |
| Other Non-op | $-24.0K | $-831.0K | $-6.0K | $-7.0K | $-155.0K | $-22.0K | $49.0K | $-8.0K | $-6.0K | $-43.0K | $-14.0K | $-197.0K | $3.0K | $20.0K | |
| Net Income | $-18M | $-30M | $-21M | $-30M | $-76M | $-94M | $-74M | $-86M | $-91M | $-83M | $-80M | $-43M | $-41M | $-38M | |
| EPS (Basic) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| EPS (Diluted) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| Shares (Basic) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| Shares (Diluted) | 83,747,104 | 82,050,618 | -144,913,285 | 73,396,435 | 72,466,203 | 71,969,411 | -118,381,262 | 64,627,847 | 58,558,145 | 58,371,480 | -96,348,323 | 56,782,379 | 48,500,516 | 42,354,520 | |
| EBITDA | $-4M | $-15M | · | $-15M | $-60M | $-79M | · | $-71M | $-77M | $-70M | · | $-36M | $-32M | $-30M |
Balance general 24
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $181M | $130M | $135M | $150M | $212M | $297M | $335M | $276M | $322M | $381M | $214M | $249M | $130M | |
| Receivables | $97M | $81M | $78M | $56M | $51M | $36M | $39M | $21M | $11M | $4M | $2M | · | · | · | |
| Inventory | $8M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $111.0K | $111.0K | · | |
| Prepaid Expense | $8M | $8M | $15M | $13M | $15M | $13M | $21M | $15M | $15M | $13M | $13M | $13M | $9M | $10M | |
| Current Assets | $296M | $277M | $229M | $208M | $219M | $265M | $360M | $374M | $305M | $340M | $397M | $227M | $258M | $140M | |
| PP&E (Net) | $971.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $299.0K | |
| Total Assets | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Accounts Payable | $5M | $6M | $5M | $1M | $4M | $12M | $11M | $7M | $8M | $8M | $13M | $6M | $4M | $5M | |
| Accrued Liabilities | $109M | $83M | $90M | $65M | $64M | $43M | $53M | $36M | $27M | $17M | $17M | $13M | $15M | $8M | |
| Current Liabilities | $154M | $125M | $132M | $93M | $92M | $74M | $86M | $65M | $47M | $43M | $39M | $24M | $22M | $14M | |
| Capital Leases | $2M | $2M | $2M | $2M | $589.0K | $0 | · | $0 | $133.0K | $292.0K | $462.0K | $628.0K | $789.0K | $945.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $12M | $12M | $12M | $12M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | |
| Total Liabilities | $671M | $642M | $697M | $663M | $656M | $633M | $632M | $574M | $553M | $505M | $487M | $255M | $247M | $234M | |
| Long-term Debt | $165M | $164M | $209M | $207M | $205M | $203M | $201M | $176M | $174M | $149M | $138M | $99M | $98M | $97M | |
| Total Debt | $165M | $164M | · | $207M | $205M | $203M | · | $176M | $174M | $149M | · | $99M | $98M | $97M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.53B | $-1.51B | $-1.48B | $-1.46B | $-1.43B | $-1.36B | $-1.26B | $-1.19B | $-1.10B | $-1.01B | $-929M | $-849M | $-806M | $-765M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-344M | $-337M | $-438M | $-423M | $-406M | $-338M | $-254M | $-187M | $-234M | $-149M | $-73M | $-18M | $18M | $-90M | |
| Liabilities + Equity | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Shares Outstanding | 80,070,048 | 79,442,367 | 71,419,025 | 71,043,149 | 70,104,419 | 69,638,070 | 68,518,238 | 68,323,938 | 58,601,025 | 58,524,101 | 57,970,044 | 56,809,085 | 56,639,085 | 43,571,140 |
Flujo de Efectivo 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $110.0K | $128.0K | $156.0K | $172.0K | $177.0K | $193.0K | $191.0K | $197.0K | $214.0K | $185.0K | $121.0K | $123.0K | $146.0K | |
| Stock-based Comp | $7M | $6M | $6M | $9M | $8M | $6M | $7M | $6M | $6M | $6M | $25M | $6M | $7M | $7M | |
| Other Non-cash | · | $9M | · | · | · | $4M | · | · | · | $8M | · | · | · | $-9M | |
| Operating Cash Flow | $-2M | $-16M | $-5M | $-14M | $-63M | $-85M | $-63M | $-64M | $-71M | $-69M | $-44M | $-32M | $-22M | $-40M | |
| CapEx | $44.0K | $61.0K | $87.0K | $27.0K | $97.0K | $18.0K | $5.0K | $44.0K | $46.0K | $40.0K | $475.0K | $939.0K | $6.0K | $214.0K | |
| Investing Cash Flow | $-44.0K | $-61.0K | $-87.0K | $-27.0K | $-97.0K | $-18.0K | $-5.0K | $-44.0K | $-46.0K | $-40.0K | $-475.0K | $-939.0K | $-6.0K | $-214.0K | |
| Debt Issued | $0 | $173M | $0 | $0 | $0 | $0 | $25M | $0 | $25M | $10M | $39M | $0 | $0 | $0 | |
| Net Debt Issued | · | $-56M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $4M | $67M | $-97.0K | $-271.0K | $80.0K | $0 | $26M | $122M | $25M | $10M | $212M | $13.0K | $142M | $14M | |
| Net Change in Cash | $2M | $51M | $-5M | $-14M | $-63M | $-85M | $-37M | $58M | $-46M | $-59M | $168M | $-33M | $119M | $-26M | |
| Free Cash Flow | · | $-16M | · | · | · | $-85M | · | · | · | $-69M | · | · | · | $-40M |
Rentabilidad 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.7% | 79.4% | · | 87.5% | 87.2% | 86.9% | · | 85.6% | 81.2% | 77.7% | · | · | · | · | |
| Operating Margin | -5.3% | -26.6% | · | -30.9% | -151.7% | -276.5% | · | -433.0% | -1055.4% | -3658.7% | · | · | · | · | |
| Net Margin | -23.7% | -52.1% | · | -60.6% | -191.9% | -330.7% | · | -523.3% | -1248.6% | -4333.3% | · | · | · | · | |
| EBITDA Margin | -5.3% | -26.4% | · | -30.9% | -151.7% | -275.9% | · | -433.0% | -1055.4% | -3647.5% | · | · | · | · | |
| ROA | -6.1% | -10.1% | · | -9.6% | -26.6% | -29.0% | · | -27.4% | -31.3% | -33.1% | · | -19.7% | -17.1% | -25.8% | |
| ROE | 4.7% | 9.0% | · | 9.8% | 23.7% | 38.7% | · | 83.5% | 84.6% | 69.4% | · | 195.7% | -772.9% | 145.0% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 2.2 | 2.4 | 3.6 | · | 5.7 | 6.5 | 7.8 | · | 9.5 | 12.0 | 9.7 | |
| Quick Ratio | 1.8 | 2.1 | · | 2.1 | 2.2 | 3.4 | · | 5.4 | 6.1 | 7.5 | · | 8.9 | 11.6 | 9.0 | |
| Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| LT Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4.4 | -4.1 | · | -3.5 | -3.3 | -3.3 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 2.7 | 2.5 | · | 1.8 | 1.8 | 1.6 | · | 1.5 | 1.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.3 | 1.3 | 1.4 | · | 1.6 | 1.3 | 1.0 | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $222M | $176M | · | $134M | $92M | $54M | · | $26M | $9M | $2M | · | · | · | · | |
| Net Income TTM | $-154M | $-230M | · | $-286M | $-347M | $-354M | · | $-303M | $-259M | $-205M | · | $-173M | $-181M | $-180M | |
| Market Cap | $869M | $883M | · | $836M | $672M | $437M | · | $1.24B | $604M | $622M | · | $589M | $811M | $311M | |
| Enterprise Value | $851M | $865M | · | $908M | $728M | $428M | · | $1.08B | $502M | $448M | · | $475M | $660M | $278M | |
| P/E | -5.3 | -3.5 | · | -2.9 | -1.8 | -1.1 | · | -3.6 | -2.2 | -2.7 | · | -2.7 | -3.3 | -1.5 | |
| P/S | 3.9 | 5.0 | · | 6.2 | 7.3 | 8.1 | · | 48.3 | 65.4 | 325.1 | · | · | · | · | |
| P/B | -2.5 | -2.6 | · | -2.0 | -1.7 | -1.3 | · | -6.6 | -2.6 | -4.2 | · | -33.1 | 46.1 | -3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 46.1 | · | |
| P / Cash Flow | · | -56.4 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| P / FCF | · | -56.2 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| EV / EBITDA | -214.6 | -56.3 | · | -59.5 | -12.1 | -5.4 | · | -15.2 | -6.5 | -6.4 | · | -13.3 | -20.8 | -9.3 | |
| EV / FCF | · | -55.1 | · | · | · | -5.0 | · | · | · | -6.5 | · | · | · | -7.0 | |
| EV / Revenue | 3.8 | 4.9 | · | 6.8 | 7.9 | 7.9 | · | 42.1 | 54.3 | 234.5 | · | · | · | · | |
| Earnings Yield | -18.8% | -28.3% | · | -34.8% | -54.6% | -89.5% | · | -28.0% | -44.5% | -36.8% | · | -36.7% | -30.6% | -64.6% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $175M | $55M | $682.0K | $0 | — |
| Margen Bruto % | 87.1% | 85.6% | 75.5% | — | — |
| Margen Operativo % | -91.4% | -502.2% | -24532.5% | — | — |
| Beneficio neto | $-221M | $-334M | $-202M | $-198M | $-144M |
| EPS Diluido | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | -0.5 | -0.8 | -1.9 | -1.3 | 1.2 |
| Ratio corriente | 1.7 | 4.2 | 10.2 | 6.1 | 9.9 |
| Ratio Rápido | 1.6 | 3.9 | 9.9 | 5.9 | 9.7 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-167M | $-267M | $-139M | $-148M | $-149M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 179 declarantes · $617.4M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 33 (+1 vs trimestre anterior) | 30 (-5 vs trimestre anterior) | 51 (-22 vs trimestre anterior) | 50 (+13 vs trimestre anterior) | +3.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135 261 406 | 12 466 489 | 21,91% | Acciones |
| Medicxi Ventures Management (Jersey) Ltd | $80 990 606 | 7 464 572 | 13,12% | Acciones |
| Carlyle Group Inc. | $37 940 367 | 3 496 808 | 6,15% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $36 627 799 | 3 375 834 | 5,93% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $28 827 842 | 2 656 944 | 4,67% | Acciones |
| NEA Management Company, LLC | $21 267 834 | 1 960 169 | 3,44% | Acciones |
| 683 Capital Management, LLC | $20 072 501 | 1 850 000 | 3,25% | Acciones |
| STATE STREET CORP | $17 211 605 | 1 586 323 | 2,79% | Acciones |
| Catalys Pacific, LLC | $16 208 316 | 1 493 854 | 2,63% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15 871 000 | 1 462 738 | 2,57% | Acciones |
| GOLDMAN SACHS GROUP INC | $15 552 303 | 1 433 392 | 2,52% | Acciones |
| WASATCH ADVISORS LP | $14 897 577 | 1 340 916 | 2,41% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $12 271 034 | 1 130 751 | 1,99% | Acciones |
| Ensign Peak Advisors, Inc | $11 413 256 | 1 051 913 | 1,85% | Acciones |
| Propel Bio Management, LLC | $11 396 384 | 1 050 358 | 1,85% | Acciones |
| Point72 Asset Management, L.P. | $11 090 794 | 1 022 193 | 1,80% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 643 446 | 796 631 | 1,40% | Acciones |
| SummitTX Capital, L.P. | $8 566 618 | 789 550 | 1,39% | Acciones |
| EcoR1 Capital, LLC | $6 781 250 | 625 000 | 1,10% | Acciones |
| PERCEPTIVE ADVISORS LLC | $5 772 200 | 532 000 | 0,93% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $5 631 975 | 519 076 | 0,91% | Acciones |
| CITADEL ADVISORS LLC | $5 216 680 | 480 800 | 0,84% | Opción de compra |
| VANGUARD GROUP INC | $4 969 501 | 299 548 | 0,80% | Acciones |
| StepStone Group LP | $4 689 364 | 422 085 | 0,76% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 547 170 | 419 094 | 0,74% | Acciones |
| Woodline Partners LP | $4 004 214 | 369 052 | 0,65% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $3 847 117 | 354 573 | 0,62% | Acciones |
| AMERIPRISE FINANCIAL INC | $3 189 358 | 293 950 | 0,52% | Acciones |
| Simplify Asset Management Inc. | $2 704 547 | 249 267 | 0,44% | Acciones |
| JPMORGAN CHASE & CO | $2 616 050 | 240 667 | 0,42% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 456 440 | 226 400 | 0,40% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 281 755 | 210 300 | 0,37% | Opción de compra |
| NewEdge Advisors, LLC | $2 212 988 | 203 962 | 0,36% | Acciones |
| Avidity Partners Management LP | $2 170 000 | 200 000 | 0,35% | Acciones |
| Jump Financial, LLC | $2 081 746 | 191 866 | 0,34% | Acciones |
| Opaleye Management Inc. | $2 013 641 | 185 589 | 0,33% | Acciones |
| CITADEL ADVISORS LLC | $2 006 176 | 184 901 | 0,32% | Acciones |
| Trexquant Investment LP | $1 886 641 | 173 884 | 0,31% | Acciones |
| Jones Hill Capital LP | $1 752 123 | 161 486 | 0,28% | Acciones |
| MARSHALL WACE, LLP | $1 751 191 | 161 400 | 0,28% | Acciones |
| XTX Topco Ltd | $1 473 777 | 135 832 | 0,24% | Acciones |
| DIADEMA PARTNERS LP | $1 409 958 | 129 950 | 0,23% | Acciones |
| SIG BROKERAGE, LP | $1 345 400 | 124 000 | 0,22% | Opción de compra |
| Engineers Gate Manager LP | $1 283 088 | 118 257 | 0,21% | Acciones |
| Virtus Investment Advisers, LLC | $1 216 708 | 112 139 | 0,20% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 178 885 | 108 653 | 0,19% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1 105 968 | 101 745 | 0,18% | Acciones |
| JANE STREET GROUP, LLC | $1 096 761 | 101 084 | 0,18% | Acciones |
| Stratos Wealth Partners, LTD. | $1 085 000 | 100 000 | 0,18% | Acciones |
| Swiss National Bank | $1 071 980 | 98 800 | 0,17% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $956 254 | 88 134 | 0,15% | Acciones |
| Stonepine Capital Management, LLC | $922 358 | 85 010 | 0,15% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $838 879 | 77 316 | 0,14% | Acciones |
| JANE STREET GROUP, LLC | $837 620 | 77 200 | 0,14% | Opción de compra |
| BlackRock, Inc. | $835 548 | 77 009 | 0,14% | Acciones |
| Campbell & CO Investment Adviser LLC | $746 035 | 68 759 | 0,12% | Acciones |
| Penn Mutual Asset Management | $681 402 | 62 802 | 0,11% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $675 771 | 62 283 | 0,11% | Acciones |
| RHUMBLINE ADVISERS | $654 740 | 60 346 | 0,11% | Acciones |
| UBS Group AG | $635 105 | 58 535 | 0,10% | Acciones |
| Birchview Capital, LP | $596 750 | 55 000 | 0,10% | Acciones |
| D. E. Shaw & Co., Inc. | $585 206 | 53 936 | 0,09% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $547 612 | 49 290 | 0,09% | Acciones |
| CITIGROUP INC | $543 661 | 50 107 | 0,09% | Acciones |
| Bank of New York Mellon Corp | $540 037 | 49 773 | 0,09% | Acciones |
| Pale Fire Capital SE | $539 386 | 49 713 | 0,09% | Acciones |
| NOMURA HOLDINGS INC | $532 735 | 49 100 | 0,09% | Opción de venta |
| Man Group plc | $528 167 | 48 679 | 0,09% | Acciones |
| AlphaQuest LLC | $468 668 | 28 250 | 0,08% | Acciones |
| ADAR1 Capital Management, LLC | $465 465 | 42 900 | 0,08% | Acciones |
| Quantbot Technologies LP | $463 892 | 42 755 | 0,08% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $459 866 | 42 384 | 0,07% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $446 866 | 40 222 | 0,07% | Acciones |
| BARCLAYS PLC | $435 660 | 40 153 | 0,07% | Acciones |
| NOMURA HOLDINGS INC | $434 000 | 40 000 | 0,07% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $432 318 | 39 845 | 0,07% | Acciones |
| Fiduciary Trust Co | $387 681 | 35 731 | 0,06% | Acciones |
| Nebula Research & Development LLC | $363 816 | 37 937 | 0,06% | Acciones |
| Persistent Asset Partners Ltd | $359 753 | 33 157 | 0,06% | Acciones |
| ALLSTATE CORP | $356 694 | 32 875 | 0,06% | Acciones |
| Squarepoint Ops LLC | $342 806 | 31 595 | 0,06% | Acciones |
| CITADEL ADVISORS LLC | $337 435 | 31 100 | 0,05% | Opción de venta |
| VANGUARD ASSET MANAGEMENT, Ltd | $309 290 | 28 506 | 0,05% | Acciones |
| MetLife Investment Management, LLC | $304 961 | 28 107 | 0,05% | Acciones |
| Kera Capital Partners, Inc. | $291 062 | 26 826 | 0,05% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $280 342 | 25 838 | 0,05% | Acciones |
| Caption Management, LLC | $260 400 | 24 000 | 0,04% | Opción de compra |
| Caption Management, LLC | $260 400 | 24 000 | 0,04% | Opción de venta |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $245 720 | 22 647 | 0,04% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $244 500 | 22 535 | 0,04% | Acciones |
| Summit Financial Wealth Advisors, LLC | $240 252 | 22 143 | 0,04% | Acciones |
| JANUS HENDERSON GROUP PLC | $239 403 | 21 500 | 0,04% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $236 198 | 18 731 | 0,04% | Acciones |
| Vanguard Global Advisers, LLC | $225 344 | 20 769 | 0,04% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $220 255 | 20 300 | 0,04% | Opción de venta |
| Invesco Ltd. | $211 065 | 19 453 | 0,03% | Acciones |
| INSPIRION WEALTH ADVISORS, LLC | $209 794 | 19 914 | 0,03% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $192 316 | 17 725 | 0,03% | Acciones |
| State of Wyoming | $191 383 | 17 639 | 0,03% | Acciones |
| PROFUND ADVISORS LLC | $187 455 | 17 277 | 0,03% | Acciones |
Informantes de la empresa 20 insiders · 9 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Steven L Basta | President and CEO | 10 de febrero de 2026 F | 373 315 | 0 | 0 | $0 |
| Molly Henderson | CFO and CBO | 7 de abril de 2025 S | 89 868 | 0 | 0 | $0 |
| Todd P. Branning | Chief Financial Officer | 28 de enero de 2021 A | — | 0 | 0 | $0 |
| Terrie Curran | President and Chief Executive | 27 de febrero de 2025 A | 360 465 | 0 | 0 | $0 |
| Azmi Nabulsi | Chief Operating Officer | 27 de febrero de 2025 A | 312 590 | 0 | 0 | $0 |
| Robert Charles Breedlove | Principal Accounting Officer | 14 de julio de 2026 F | 59 925 | 0 | 2 | $-12 652 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 10 de febrero de 2026 F | 88 660 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 2 de enero de 2026 A | 226 715 | 0 | 0 | $0 |
| Anthony J. Guzzo | VP, Chief Accounting Officer | 19 de enero de 2022 A | 8 399 | 0 | 0 | $0 |
| Asit Parikh | Consejero | 22 de mayo de 2026 G | 148 500 | 0 | 0 | $0 |
| Mark Stenhouse | Consejero | 19 de mayo de 2026 A | 54 122 | 0 | 0 | $0 |
| Theodore R Schroeder | Consejero | 19 de mayo de 2026 A | 45 122 | 0 | 0 | $0 |
| James N. Topper | Consejero | 19 de mayo de 2026 A | 66 718 | 0 | 0 | $0 |
| Frank Karbe | Consejero | 19 de mayo de 2026 A | 91 622 | 0 | 0 | $0 |
| Michael F Cola | Consejero | 19 de mayo de 2026 A | 63 920 | 0 | 0 | $0 |
| Heidi Kunz | Consejero | 19 de mayo de 2026 A | 54 122 | 0 | 0 | $0 |
| David A Socks | Consejero | 23 de mayo de 2024 A | 19 500 | 0 | 0 | $0 |
| Tadataka Yamada | Consejero | 21 de mayo de 2021 A | — | 0 | 0 | $0 |
| Jonathan S. Edwards | Consejero | 29 de octubre de 2019 C | 47 984 | 0 | 0 | $0 |
| Takeda Pharmaceutical Company Limited | — | 24 de enero de 2024 S | 3 755 583 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×3 presentaciones | 4 de noviembre de 2025 | 8,60% | Enmienda | — | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×8 presentaciones | 22 de agosto de 2024 | — | Presentación inicial | Inversión pasiva | SEC |
| Takeda Pharmaceutical Company Limited ×3 presentaciones | 10 de abril de 2024 | — | Presentación inicial | — | SEC |
| Frazier Life Sciences IX, L.P ., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes | 26 de mayo de 2023 | — | Presentación inicial | Inversión pasiva | SEC |
| S.S. OR ×5 presentaciones | 12 de noviembre de 2021 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 34 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,23% | 64 997 NS | 30 de abril de 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,01% | 11 659 NS | 30 de abril de 2026 | N-PORT |
| IHE · iShares Trust | 0,09% | 182 732 SH | 8 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,09% | 166 627 SH | 8 de agosto de 2026 | Diario |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 49 552 NS | 31 de mayo de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 4 339 SH | 8 de agosto de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 78 352 SH | 8 de agosto de 2026 | Diario |
| BIB · ProShares Trust | 0,04% | 2 912 NS | 31 de mayo de 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 414 853 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 283 184 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30 521 SH | 8 de agosto de 2026 | Diario |
| IWN · iShares Trust | 0,02% | 329 427 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,02% | 20 112 NS | 30 de abril de 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 18 573 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 253 335 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,01% | 2 182 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 586 438 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 15 003 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 148 237 SH | 8 de agosto de 2026 | Diario |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236 650 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 21 971 NS | 30 de abril de 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2 641 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 129 591 SH | 8 de agosto de 2026 | Diario |
| UWM · ProShares Trust | 0,01% | 1 707 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 727 NS | 31 de mayo de 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2 570 SH | 8 de agosto de 2026 | Diario |
| HDG · ProShares Trust | 0,00% | 43 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 333 NS | 31 de mayo de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 205 NS | 31 de mayo de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 79 259 SH | 8 de agosto de 2026 | Diario |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 33 490 NS | 31 de mayo de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9 288 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 007 668 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 478 SH | 8 de agosto de 2026 | Diario |